⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer

Official Title: Can Patients With Residual Cancer After Chemotherapy for Early Breast Cancer be Identified With Multiple Ultrasound-guided Biopsies?

Study ID: NCT04118192

Conditions

Breast Cancer

Study Description

Brief Summary: A prospective non-randomised multi-centre feasibility study to assess if patients with residual cancer following dual-targeted neoadjuvant chemotherapy treatment for HER2-positive, ER-negative early breast cancer can be identified by multiple ultrasound (US)-guided tumour bed core biopsies

Detailed Description: The NOSTRA-Feasibility study is designed to determine if it is safe to omit surgery after the planned neoadjuvant chemotherapy plus dual-targeted anti-HER2 treatment. The study is needed to determine whether patients with residual cancer can be identified by histological examination of multiple ultrasound-guided tumour bed core biopsies following dual-targeted neoadjuvant treatment for HER2-positive, ER-negative early primary breast cancer and whether there is concordance between local pathology reporting and central pathology reporting by the trials expert pathologists.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Basildon Hospital, Basildon, Essex, United Kingdom

Belfast City Hospital, Belfast, , United Kingdom

City Hospital, Birmingham, , United Kingdom

Queen Elizabeth Hospital, Birmingham, , United Kingdom

Blackpool Teaching Hospitals NHS Trust, Blackpool, , United Kingdom

Southmead Hospital, Bristol, , United Kingdom

University Hospital of Llandough, Cardiff, , United Kingdom

Cheltenham General Hospital, Cheltenham, , United Kingdom

Dumfries and Galloway Royal Infirmary, Dumfries, , United Kingdom

Western General, Edinburgh, , United Kingdom

Northwick Park Hospital, Harrow, , United Kingdom

St James's University Hospital, Leeds, , United Kingdom

Royal Liverpool Hospital, Liverpool, , United Kingdom

Royal Marsden Hospital, London, , United Kingdom

Borders General Hospital, Melrose, , United Kingdom

Royal Victoria Infirmary, Newcastle Upon Tyne, , United Kingdom

Nottingham City Hospital, Nottingham, , United Kingdom

Peterborough City Hospital, Peterborough, , United Kingdom

Poole Hospital, Poole, , United Kingdom

Weston Park Hospital, Sheffield, , United Kingdom

Southampton General Hospital, Southampton, , United Kingdom

Singleton Hospital, Swansea, , United Kingdom

Arrowe Park Hospital, Upton, , United Kingdom

Thomas Linacre Centre, Wigan, , United Kingdom

Contact Details

Name: Daniel Rea

Affiliation: University of Birmingham

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: